Skip to main content
. 2020 Aug 20;48(8):0300060520946872. doi: 10.1177/0300060520946872

Figure 2.

Figure 2.

Forest plot of the relationship between the use of sorafenib and outcome of treatment in patients with hepatocellular carcinoma with microvascular invasion.